During the past decade, University of Cincinnati Cancer Center-UC Medical Center conducted 156 clinical trials. In the 10-year time frame, 156 clinical trials started and 79 clinical trials were completed, i.e. on average, 50.6% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 55 clinical trials were completed. i.e. 80.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Cincinnati Cancer Center-UC Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 87 trials, followed by "SWOG Cancer Research Network" with 71 trials sponsored, "Gynecologic Oncology Group" with 48 trials sponsored, "Radiation Therapy Oncology Group" with 24 trials sponsored and "Alliance for Clinical Trials in Oncology" with 24 trials sponsored. Other sponsors include 114 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Cincinnati Cancer Center-UC Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 219 trials as a collaborator, "NRG Oncology" with 39 trials as a collaborator, "SWOG Cancer Research Network" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator and "Cancer and Leukemia Group B" with 9 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "University of Cincinnati Cancer Center-UC Medical Center" are "Ovarian Cancer" (22 trials), "Breast Cancer" (16 trials), "Lung Cancer" (16 trials), "Head and Neck Cancer" (14 trials) and "Endometrial Cancer" (13 trials). Many other conditions were trialed in "University of Cincinnati Cancer Center-UC Medical Center" in a lesser frequency.

Most popular intervention types in "University of Cincinnati Cancer Center-UC Medical Center" are "Drug" (311 trials), "Other" (131 trials), "Biological" (106 trials), "Radiation" (98 trials) and "Procedure" (84 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (70 trials), "Quality-of-Life Assessment" (57 trials), "radiation therapy" (36 trials), "Carboplatin" (35 trials) and "Paclitaxel" (34 trials). Other intervention names were less common.

The vast majority of trials in "University of Cincinnati Cancer Center-UC Medical Center" are 253 trials for "All" genders, 104 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "University of Cincinnati Cancer Center-UC Medical Center". undefined are not yet recruiting, 66 are recruiting, 95 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 160 completed trials in University of Cincinnati Cancer Center-UC Medical Center, 7 suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in University of Cincinnati Cancer Center-UC Medical Center, 36 "Phase 1" clinical trials were conducted, 181 "Phase 2" clinical trials and 168 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".